Saline Laxatives Market

研究執行與發布：Coherent Market Insights　·　發布日期 2026-01-20　·　151 頁
由量子訊息有限公司（Quantum Information）在台灣代理銷售與提供授權諮詢。

2026 年市場規模: USD 557.3 Mn
2033 年預估規模: USD 783.8 Mn
年複合成長率 CAGR: 5%

以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。

出版商 Coherent Market Insights 產業別 Healthcare & Life Sciences出版日期 2026-01-20頁數 151報告編號 CMI2195

授權報價

Single User Price	$4,500 USD
Enterprise License	$10,000 USD

洽詢購買申請 Sample

完整報告名稱與涵蓋範圍

Saline Laxatives Market, By Age Group (Pediatric and Adult), By Route of Administration (Oral and Rectal), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

報告摘要

Saline laxatives are soluble inorganic salts that contain multivalent cations or anions. Examples of saline laxatives include citrate salts (Royvac), magnesium preparations (Phillips’ Milk of Magnesia), sulfate salts, and sodium phosphate. Saline laxatives can be administered orally as well rectal route of administration. Oral saline (salt) laxatives are used for rapid emptying lower intestine and bowel. Oral saline laxatives are most commonly used in treating occasional constipation. Rectal saline laxatives have applications in various health conditions such as during labor pain, post birth, during preparation for examination or surgery, to normalize bowel functions, and in post-surgical conditions. Market Dynamics Increasing prevalence of constipation due to sedentary lifestyle and low consumption of fluids and fiber diet are major factors that are expected to drive the global saline laxative market growth over the forecast period. For instance, according to a National Center for Biotechnology Information (NCBI) study 2016, chronic constipation is a common complaint received by both gastroenterologists and primary care physicians, with prevalence estimates ranging from 1% to 8% among the North America population. Moreover, constipation occurs more frequently in women, with a female/male ratio ranging from 1.01 to 3.77. Various saline (salt) solutions such as magnesium citrate, magnesium hydroxide (MOM), magnesium sulfate (Epsom salts), sodium phosphates, and polyethylene glycol are used in preparing oral saline laxatives. Moreover, manufacturers are focused on offering saline laxatives for oral use, which is expected to drive growth of the oral segment in saline laxatives market over the forecast period. For instance, Pendopharm offers LAX-A DAY, polyethylene Glycol 3350 Powder (salt) for oral solution. The product was launched in August 2017. Key features of the study • This report provides in-depth analysis of the global saline laxatives market, market size (USD Mn), and compound annual growth rate (CAGR %) over the forecast period (2026–2033), considering 2025 as the base year • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market • This study also provides key insights about market drivers, restraints, opportunities, new technology launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players • It profiles leading players in the global saline laxatives market based on the following parameters – company overview, financial performance, technology portfolio, geographical presence, distribution strategies, key developments, and strategies • Key players covered as a part of this study include Bayer AG, Beutlich Pharmaceuticals LLC., Prestige Consumer Healthcare Inc, Cardinal Health, Inc., Major Pharmaceuticals, Dynarex Corporation, Pharmascience Inc, and Salix Pharmaceuticals. • Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to future technology launches, government initiatives, technological upgradation, market expansion, and marketing tactics • The global saline laxatives market report caters to various stakeholders in this market, including investors, technology manufacturers, distributors, and suppliers for global saline laxatives market, research and consulting firms, new entrants, and financial analysts Market Segmentation • Age Group Insights (Revenue, USD Mn, 2026 - 2033) o Pediatric o Adult • Route of Administration Insights (Revenue, USD Mn, 2026 - 2033) o Oral o Rectal • Distribution Channel Insights (Revenue, USD Mn, 2026 - 2033) o Hospital Pharmacies o Retail Pharmacies o Online Pharmacies • Regional Insights (Revenue, USD Mn, 2026 - 2033) o North America  U.S.  Canada o Latin America  Brazil  Argentina  Mexico  Rest of Latin America o Europe  Germany  U.K.  Spain  France  Italy  Russia  Rest of Europe o Asia Pacific  China  India  Japan  Australia  South Korea  ASEAN  Rest of Asia Pacific o Middle East  GCC Countries  Israel  Rest of Middle East o Africa  South Africa  North Africa  Central Africa • Key Players Insights o Bayer AG o Beutlich Pharmaceuticals LLC. o Prestige Consumer Healthcare Inc o Cardinal Health, Inc. o Major Pharmaceuticals o Dynarex Corporation o Pharmascience Inc o Salix Pharmaceuticals

目錄 Table of Contents

Table of Contents 1. Research Objectives and Assumptions o Research Objectives o Assumptions o Abbreviations 2. Market Purview o Report Description  Market Definition and Scope o Executive Summary  Market Snippet, By Age Group  Market Snippet, By Route of Administration  Market Snippet, By Distribution Channel  Market Snippet, By Region o Coherent Opportunity Map (COM) 3. Market Dynamics, Regulations, and Trends Analysis o Market Dynamics  Drivers  Restraints  PEST Analysis  PORTER’s Five Forces Analysis  Market Opportunities  Regulatory Scenario  Key Developments  Industry Trend 4. Global Saline Laxatives Market, By Age Group, 2026-2033, (USD Mn) o Introduction  Market Share Analysis, 2026, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 - 2033  Segment Trends o Pediatric  Market Share Analysis, 2026, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends o Adult  Market Share Analysis, 2026, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends 5. Global Saline Laxatives Market, By Route of Administration, 2026-2033, (USD Mn) o Introduction  Market Share Analysis, 2026, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 - 2033  Segment Trends o Oral  Market Share Analysis, 2026, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends o Rectal  Market Share Analysis, 2026, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends 6. Global Saline Laxatives Market, By Distribution Channel, 2026-2033, (USD Mn) o Introduction  Market Share Analysis, 2026, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 - 2033  Segment Trends o Hospital Pharmacies  Market Share Analysis, 2026, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends o Retail Pharmacies  Market Share Analysis, 2026, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends o Online Pharmacies  Market Share Analysis, 2026, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends 7. Global Saline Laxatives Market, By Region, 2026-2033, (USD Mn) o Introduction  Market Share Analysis, By Region, 2026, 2028, and 2033 (%)  Y-o-Y Growth Analysis, For Region, 2021 - 2033 o North America  Market Share Analysis, By Country, 2026, 2028 and 2033 (%)  Y-o-Y Growth Analysis, For Country, 2021 - 2033  Market Size and Forecast, By Age Group, 2026- 2033, (USD Mn)  Market Size and Forecast, By Route of Administration, 2026- 2033, (USD Mn)  Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Mn)  Market Size and Forecast, By Country, 2026- 2033, (USD Mn) o U.S. o Canada o Latin America  Market Share Analysis, By Country, 2026, 2028 and 2033 (%)  Y-o-Y Growth Analysis, For Country, 2021 - 2033  Market Size and Forecast, By Age Group, 2026- 2033, (USD Mn)  Market Size and Forecast, By Route of Administration, 2026- 2033, (USD Mn)  Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Mn)  Market Size and Forecast, By Country, 2026- 2033, (USD Mn) o Brazil o Argentina o Mexico o Rest of Latin America o Europe  Market Share Analysis, By Country, 2026, 2028 and 2033 (%)  Y-o-Y Growth Analysis, For Country, 2021 - 2033  Market Size and Forecast, By Age Group, 2026- 2033, (USD Mn)  Market Size and Forecast, By Route of Administration, 2026- 2033, (USD Mn)  Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Mn)  Market Size and Forecast, By Country, 2026- 2033, (USD Mn) o U.K. o Germany o Italy o France o Spain o Russia o Rest of Europe o Asia Pacific  Market Share Analysis, By Country, 2026, 2028 and 2033 (%)  Y-o-Y Growth Analysis, For Country, 2021 - 2033  Market Size and Forecast, By Age Group, 2026- 2033, (USD Mn)  Market Size and Forecast, By Route of Administration, 2026- 2033, (USD Mn)  Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Mn)  Market Size and Forecast, By Country, 2026- 2033, (USD Mn) o China o India o Japan o ASEAN o Australia o South Korea o Rest of Asia Pacific o Middle East  Market Share Analysis, By Country, 2026, 2028 and 2033 (%)  Y-o-Y Growth Analysis, For Country, 2021 - 2033  Market Size and Forecast, By Age Group, 2026- 2033, (USD Mn)  Market Size and Forecast, By Route of Administration, 2026- 2033, (USD Mn)  Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Mn)  Market Size and Forecast, By Country, 2026- 2033, (USD Mn) o GCC Countries o Israel o Rest of Middle East o Africa  Market Share Analysis, By Country/Region, 2026, 2028 and 2033 (%)  Y-o-Y Growth Analysis, For Country/Region, 2021 - 2033  Market Size and Forecast, By Age Group, 2026- 2033, (USD Mn)  Market Size and Forecast, By Route of Administration, 2026- 2033, (USD Mn)  Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Mn)  Market Size and Forecast, By Country, 2026- 2033, (USD Mn) o South Africa o North Africa o Central Africa 8. Competitive Landscape o Heat Map Analysis o Market Share Analysis (3x3 Matrix) o Company Profiles  Bayer AG o Company Overview o Product Type Portfolio o Recent Developments/Updates  Beutlich Pharmaceuticals LLC. o Company Overview o Product Type Portfolio o Recent Developments/Updates  Prestige Consumer Healthcare Inc o Company Overview o Product Type Portfolio o Recent Developments/Updates  Cardinal Health, Inc. o Company Overview o Product Type Portfolio o Recent Developments/Updates  Civil Apparel o Company Overview o Product Type Portfolio o Recent Developments/Updates  Major Pharmaceuticals o Company Overview o Product Type Portfolio o Recent Developments/Updates  Dynarex Corporation o Company Overview o Product Type Portfolio o Recent Developments/Updates  Pharmascience Inc o Company Overview o Product Type Portfolio o Recent Developments/Updates  Salix Pharmaceuticals o Company Overview o Product Type Portfolio o Recent Developments/Updates 9. Analyst Recommendation o Wheel of Fortune o Analyst View o Coherent Opportunity Map 10. Section o References o Research Methodology o About Us and Sales Contact

提及公司

Bayer AGBeutlich Pharmaceuticals LLC.Prestige Consumer Healthcare IncCardinal Health, Inc.Major PharmaceuticalsDynarex CorporationPharmascience IncSalix Pharmaceuticals

同分類最新報告（醫療與生命科學）

常見問題

這份報告可以先索取樣本嗎？

可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。

報告價格如何計算？

報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。

下單後多久交付？如何付款？

一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。

量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・聯絡我們